Pacific Image Electronics Co., Ltd. · TPEX:6228

Pacific Image Electronics — Investor Presentation (September 2025)

23 slides from Pacific Image Electronics's investor presentation, Sep 16, 2025

  1. Slide 1: Pacific Image Electronics Investor Conference 2025

    Stock Code: 6228 Pacific Image Electronics Investor Conference 2025 September 16, 2025

  2. Slide 2: Outline

    Outline • Disclaimer • Company Profile • Organization and Functions • Main Products and Applications • R&D Achievements • 2020 ~ 2024 Operating Results • 2023~2025 First 2 Quarters Operating Results • Industry Trends and Company Future Outlook • Q&A 2

  3. Slide 3: Disclaimer

    Disclaimer • This presentation and related information released simultaneously contain predictive information obtained from internal and external sources of the company. • The company's actual future operating results, financial condition, and business prospects may differ from the estimates express

  4. Slide 4: Company Profile

    1993 Company Established 2003 Listed on Taiwan Stock Market Headquarters: Xizhi District, New Taipei City, Taiwan US Subsidiary: Los Angeles Chairman: Wei-Chao Kao General Manager: Chih-Yuan Tseng Chief Financial Officer: Su-Hua Chen Film Scanner Gel Imaging System Diagnostic Detector 4

  5. Slide 5: Company history and transformation timeline

    1993 1999 2004 2017 2025 Diagnostic Detector Home Use Gel Imaging System Film Scanner Multifunction Printer Architecture Transforming into the Entering the Startup Found the Blue Biotechnology Field Clinical & Home Ocean of Starting from Testing Field and Scanners Research5 Market Diversification

  6. Slide 6: Organizational Functions

    Organizational Functions PIE PIETPE HQs PIEUS Refer next page Warehouse Dist. 6

  7. Slide 7: PIETPE HQs organization chart

    PIETPE HQs ‘ant PACIFI IMAGE Wwww.scanace,com Head of Corporate Audit Committees | Board of Governancee Directorse Remuneration ; , . Audit Offices Committees Chairman Presidente General Department of Imaging and Intelligent Management Of ficee Biomedical Sciences» Department» Management Engineering

  8. Slide 8: Main Product Lines

    Main Product Lines Film Scanner Gel Image System Diagnostic Detector 8

  9. Slide 9: Main Product - Film Scanners

    Main Product - Film Scanners Amounts of Frames Auto Batch Batch PrimeFilm XA Plus Scan PowerFilm Plus PowerSlide X Plus Entry Level Comprehensive Single Frame Scan PrimeFilm 120 Pro Plus PrimeFilm XE Plus PrimeFilm 7250 Plus 135 Film 135 Slide 135 Film/Slide 120 and 135 Film/Slide Film Types 9

  10. Slide 10: Main Product - Gel Imaging Systems

    Main Product - Gel Imaging Systems GelCap Glite T8 Glite 600 Slite 600 ChemLux 10

  11. Slide 11: Main Product - Diagnostic Detector

    Main Product - Diagnostic Detector Total Solution: From RD to Market Application POCT RTV: Rapid Test View RS ST5 Series & RS One 家用 BHR: bHome Reader RS PH Series 11

  12. Slide 12: R&D Achievements

    R&D Achievements • Film Scanner – The industry's most comprehensive film-compatible solution – Optical resolution of 5,000 dpi, far exceeding competitors • Gel Imaging System – From the smallest mobile phone solution to the largest and most comprehensive visible light, fluorescent, and luminescent s

  13. Slide 13: 2020-2024 Operating Results

    2020-2024 Operating Results Unit: 1,000 NT$ 120,000 100,000 80,000 60,000 40,000 20,000 0 (20,000) (40,000) (60,000) Year-2024 Year-2023 Year-2022 Year-2021 Year-2020 Net (loss) profit after tax (22,132) (33,442) (25,584) (5,240) (28,848) Sales revenue 42,740 34,181 45,962 98,430 74,678 13

  14. Slide 14: Comparison of Consolidated Comprehensive IS for H1 2024 and 2025

    Comparison of Consolidated Comprehensive IS for H1 2024 and the same period in 2025 Unit: 1,000 NT$ ITEM Y2025 H1 Y2024H1 Difference Sales revenue 26,813 21,572 5,241 Cost of good sold (16,188) (13,173) (3,015) Gross profit 10,625 8,399 2,226 Operating expenses 19,343 22,876 (3,533) Net (loss) profi

  15. Slide 15: Comparison of Consolidated Comprehensive IS for 2024 and 2023

    Comparison of Consolidated Comprehensive IS for 2024 and 2023 Unit: 1,000 NT$ ITEM Y2024 Y2023 Difference Sales revenue 42,740 34,181 8,559 Cost of good sold (30,421) (22,088) (8,333) Gross profit 12,319 12,093 226 Operating expenses 41,316 43,989 (2,673) Net (loss) profit from operations (28,997) (

  16. Slide 16: Comparison of Operating Revenue by Region

    Comparison of Operating Revenue by Region Unit: 1,000 NT$ 2025 H1 2024 H1 Compare with Pre. Year Region Sales Amount Sales GP Sales Amount Sales GP Sales Amount Sales GP N. America 10,028 5,653 9,825 3,816 102% 148% Asia 10,385 3,048 6,709 2,460 155% 124% EU 6,367 1,906 4,845 2,000 131% 95% Others 3

  17. Slide 17: Comparison of Operating Revenue by Product

    Comparison of Operating Revenue by Product Unit: 1,000 NT$ 2025 H1 2024 H1 Compare with Pre. Year Region Sales Amount Sales GP Sales Amount Sales GP Sales Amount Sales GP N. America 10,028 5,653 9,825 3,816 102% 148% Asia 10,385 3,048 6,709 2,460 155% 124% EU 6,367 1,906 4,845 2,000 131% 95% Others

  18. Slide 18: Extend from Core

    Extend from Core Physical World Digital World Clinic & Home Diagnostic Use Market Detecto Gel Lab. Research Imager Market Bio. Field Image Process Consumer Field Film Scanner

  19. Slide 19: Present: Testing Platform

    Present: Testing Platform Pandemic Human Diagnosis Pet Food Safety Environment 19

  20. Slide 20: Post-Pandemic: Decentralization

    Post-Pandemic: Decentralization Centralize De-centralize • PCR • Rapid Test • Lab. • Home • Manual Report • Internet • Hospital • Telemedicine 20

  21. Slide 21: NIH: RADx Project

    ‘ant NIH : RADx Project PACTIGIMAGE www.scanace.com EE An official website of the United States government Here’s how you know v Virtual Tour | En Espafiol National Institutes of Health Turning Discovery Into Health Search NIH Home > Research & Training >» Medical Research Initiatives | Medical Rese

  22. Slide 22: Future: De-Centralized Applications

    Future: De-Centralized Applications • Infectious Disease Testing Bulletin • CoVID/FluA/FluB/RSV • Personal Healthcare • Immune System 雲端服務 Monitoring • Cardiovascular Triple Factor Test • Cortisol Test • Telemedicine • Newborn Triple Factor Test 家用方案 22

  23. Slide 23: Q&A

    Q&A 23

Pacific Image Electronics — Investor Presentation (September 2025) on 6ix